Telomerase and N-Cadherin Differential Importance in Adrenocortical Cancers and Adenomas

Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma

(2016) Siyuan Zheng et al.   CANCER CELL

Reactivation of telomerase in cancer

(2016) Semih Can Akincilar et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

hTERT promotes cell adhesion and migration independent of telomerase activity

(2016) Haiying Liu et al.   Scientific Reports

Noncanonical Functions of Telomerase: Implications in Telomerase-Targeted Cancer Therapies

(2014) Yinghui Li et al.   CANCER RESEARCH

The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors

(2014) Tiantian Liu et al.   ENDOCRINE-RELATED CANCER

Telomerase reverse transcriptase promoter mutations in tumors originating from the adrenal gland and extra-adrenal paraganglia

(2014) Thomas G Papathomas et al.   ENDOCRINE-RELATED CANCER

Telomerase promoter mutations in cancer: an emerging molecular biomarker?

(2014) João Vinagre et al.   VIRCHOWS ARCHIV

Super-Resolution Fluorescence Imaging of Telomeres Reveals TRF2-Dependent T-loop Formation

(2013) Ylli Doksani et al.   CELL

Telomere Length Influences Cancer Cell Differentiation In Vivo

(2013) K. Hirashima et al.   MOLECULAR AND CELLULAR BIOLOGY

Trouble upstream

(2013) E. Elizabeth Patton et al.   NATURE

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

(2013) P. J. Killela et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

TERT Promoter Mutations in Familial and Sporadic Melanoma

(2013) S. Horn et al.   SCIENCE

Highly Recurrent TERT Promoter Mutations in Human Melanoma

(2013) F. W. Huang et al.   SCIENCE

Frequency of TERT promoter mutations in human cancers

(2013) João Vinagre et al.   Nature Communications

The emerging role of the molecular marker p27 in the differential diagnosis of adrenocortical tumors

(2013) Sofia S Pereira et al.   Endocrine Connections

Adrenocortical carcinoma: Past, present, and future

(2012) Jennifer LaFemina et al.   JOURNAL OF SURGICAL ONCOLOGY

E/N-cadherin switch mediates cancer progression via TGF-β-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma

(2011) K Araki et al.   BRITISH JOURNAL OF CANCER

Similarities and differences between “uncapped” telomeres and DNA double-strand breaks

(2011) James M. Dewar et al.   CHROMOSOMA

Soluble E-cadherin promotes cell survival by activating epidermal growth factor receptor☆

(2011) Landon J. Inge et al.   EXPERIMENTAL CELL RESEARCH

Transcriptome Analysis Reveals that p53 and  -Catenin Alterations Occur in a Group of Aggressive Adrenocortical Cancers

(2010) B. Ragazzon et al.   CANCER RESEARCH

Telomeres in cancer and ageing

(2010) L. E. Donate et al.   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

The Weiss system for evaluating adrenocortical neoplasms: 25 years later

(2009) Sean K. Lau et al.   HUMAN PATHOLOGY

Understanding and exploitinghTERTpromoter regulation for diagnosis and treatment of human cancers

(2008) Satoru Kyo et al.   CANCER SCIENCE

Cadherin switching

(2008) M. J. Wheelock et al.   JOURNAL OF CELL SCIENCE